MYC and neoplasm: Also, upregulation of miR-17-92 decreased thrombospondin-1 (THBS1) expression that enhanced angiogenesis, indicating a MYC-miR-17-92 dependent pathogenesis in the MYC-amplified hemangiosarcoma tumor tissues.